Simbrinza

Simbrinza Description

Manufacturer:

Novartis

Distributor:

DKSH
Full Prescribing Info
Description
1 mL of suspension contains 10 mg of brinzolamide and 2 mg of brimonidine tartrate equivalent to 1.3 mg of brimonidine.
Excipient with known effect: Each mL of suspension contains 0.03 mg of benzalkonium chloride.
Excipients/Inactive Ingredients: Benzalkonium chloride; Propylene glycol; Carbomer 974P; Boric acid; Mannitol; Sodium chloride; Tyloxapol; Hydrochloric acid and/or sodium hydroxide (to adjust pH); Purified water.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in